IWC
CORT icon

Integrated Wealth Concepts’s Corcept Therapeutics CORT Stock Holding History

Integrated Wealth Concepts’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,979
Closed -$248K – 1700
2025
Q3 		$248K Buy
+2,979
New +$216K ﹤0.01% 1745

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Integrated Wealth Concepts's CORT Position: Q4 2025 in Review

Integrated Wealth Concepts sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 2,979 shares — an estimated $248K sold.

Integrated Wealth Concepts first reported a position in CORT in Q3 2025 and held it in 1 quarter. The position peaked at $248K in Q3 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Integrated Wealth Concepts reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Integrated Wealth Concepts sold 2,979 Corcept Therapeutics shares in Q4 2025, an estimated $248K.
  • Integrated Wealth Concepts first reported a position in Corcept Therapeutics in Q3 2025 and held it in 1 quarter.
  • Integrated Wealth Concepts's Corcept Therapeutics position peaked at $248K in Q3 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Integrated Wealth Concepts's 13F filing for Q4 2025, filed 13 Feb 2026.